首頁 > 市場調查報告書 > 醫療設備

e保健

市場調查報告書

商品編碼

2112925

數位治療個人化平台市場：預測（至2034年）－按產品、組件、技術、應用、最終用戶和地區分類的全球分析

Digital Therapeutics Personalization Platforms Market Forecasts to 2034 - Global Analysis By Product, Component, Technology, Application, End User and By Geography

出版日期: 2026年08月01日 | 出版商:

Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄圖表

根據 Stratistics MRC 的數據，全球數位治療個人化平台市場預計將在 2026 年達到 25 億美元，在預測期內以 17.2% 的複合年成長率成長，到 2034 年達到 89 億美元。

數位治療個人化平台是基於軟體的解決方案，可為患者提供根據其個別健康狀況、行為和偏好量身定做的循證治療性介入。這些平台利用人工智慧、機器學習以及來自穿戴式裝置和感測器的即時數據，動態調整治療方案，確保最佳治療效果和患者參與度。它們旨在治療、管理和預防多種疾病，涵蓋心理健康和慢性病等領域。

向以病人為中心的精準醫療轉型

從標準化的治療模式轉向以患者為中心的精準醫療，是推動基於個人獨特的基因、行為和環境數據進行個人化治療的平台發展的主要動力。數位治療平台使醫療服務提供者能夠提供更有效、依從性更高、更個人化的介入措施。對結果導向醫療的日益重視以及個人化治療已證實的臨床療效，正在加速這些平台的應用。

臨床證據和監管標準化

驗證個人化數位療法的有效性和安全性，仍需強力的臨床證據，這仍然是一項重大挑戰，需要耗資龐大且耗時漫長的隨機對照試驗。人工智慧驅動的自適應療法缺乏標準化的監管流程，這給開發者帶來了不確定性，並可能延緩產品上市。這種對嚴格臨床檢驗的需求可能成為一大障礙，尤其對於中小企業而言，並可能限制創新步伐。

與穿戴式裝置的整合

將個人化平台與穿戴式裝置和遠端監測技術相結合，為持續收集患者數據並即時調整治療方案提供了重要機會。這使得動態、響應式介入成為可能，能夠根據患者病情的即時變化進行調整。消費者對穿戴式裝置的日益普及以及先進感測器的發展，正在為數據驅動的個人化和市場成長開闢新的途徑。

資料隱私和安全問題

由於數位治療平台依賴大量高度敏感的患者健康數據，因此極易成為網路攻擊和資料外洩的目標，這可能導致重大經濟損失和患者信任危機。遵守全球各種資料隱私法規（例如 HIPAA 和 GDPR）十分複雜，也增加了合規負擔。大規模的隱私醜聞可能會嚴重損害整個行業的信譽，並阻礙其廣泛應用。

新型冠狀病毒（COVID-19）的影響：

疫情顯著加速了數位醫療和遠端醫療的普及，並提升了人們對數位療法的興趣。疫情中期，人們對便利、非接觸式心理健康支援的需求日益成長，進一步推動了這些平台的普及。疫情結束後，人們的關注點轉向將這些解決方案整合到主流醫療服務體系中，市場呈現持續成長的態勢。

在預測期內，慢性病平台細分市場預計將佔據最大的市場佔有率。

鑑於糖尿病和心血管疾病等慢性病的高發生率，以及對長期、個人化管理策略的需求，預計慢性病平台細分市場將在預測期內佔據最大的市場佔有率。此細分市場的優勢在於能夠透過與各種監測設備整合，提供數據驅動的持續支持，從而改善患者預後並降低醫療成本。慢性病管理已證實的投資報酬率 (ROI) 以及對價值醫療日益成長的關注，進一步鞏固了該細分市場的主導地位。

預計在預測期內，軟體領域將呈現最高的複合年成長率。

在預測期內，軟體領域預計將呈現最高的成長率，這主要得益於人工智慧演算法的持續創新以及面向患者和臨床醫生的複雜、易用型應用程式的開發。基於雲端的人工智慧個人化引擎的日益普及，使得這些平台更具可擴展性和易用性。遠端醫療和遠端監測的快速發展，推動了對整合軟體解決方案的需求，進而加速了這一關鍵領域的成長。

市佔率最大的地區：

在預測期內，北美預計將佔據數位療法個人化平台市場最大的佔有率，這主要得益於其先進的醫療基礎設施、高昂的醫療費用支出以及數位健康技術的廣泛應用。美國憑藉其有利的報銷政策、對數位療法的強大監管支持以及人工智慧驅動的個人化療法平台日益普及，在區域市場中處於主導地位。

複合年成長率最高的地區：

在預測期內，亞太地區預計將成為數位療法個人化平台市場中複合年成長率最高的地區，這主要得益於醫療保健的快速數位化、智慧型手機和網際網路普及率的不斷提高以及慢性病患病率的上升。中國、印度、日本和韓國等國家正在大力投資數位健康計畫和遠端醫療基礎設施。醫療保健服務的可及性提高、政府的支持性政策、個人化護理解決方案的日益普及以及人們對數位療法的認知不斷增強，預計將加速全部區域的市場成長。

免費客製化服務：

訂閱本報告的用戶可享有以下免費自訂選項之一：

公司簡介
- 對其他公司（最多 3 家公司）進行全面分析
- 對主要公司進行SWOT分析（最多3家公司）
區域分類
- 根據客戶興趣量身定做的主要國家/地區的市場估算、預測和複合年成長率（註：基於可行性檢查）
競爭性標竿分析
- 根據產品系列、地理覆蓋範圍和策略聯盟對領先公司進行基準分析。

北美洲
- 美國
- 加拿大
- 墨西哥
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 荷蘭
- 比利時
- 瑞典
- 瑞士
- 波蘭
- 其他歐洲國家
亞太地區
- 中國
- 日本
- 印度
- 韓國
- 澳洲
- 印尼
- 泰國
- 馬來西亞
- 新加坡
- 越南
- 其他亞太國家
南美洲
- 巴西
- 阿根廷
- 哥倫比亞
- 智利
- 秘魯
- 其他南美國家
世界其他地區（RoW）
- 中東
  - 沙烏地阿拉伯
  - 阿拉伯聯合大公國
  - 卡達
  - 以色列
  - 其他中東國家
- 非洲
  - 南非
  - 埃及
  - 摩洛哥
  - 其他非洲國家

第11章策略市場資訊

產業加值網路與供應鏈評估
空白區域和機會地圖
產品演進與市場生命週期分析
通路、經銷商和打入市場策略的評估

第12章產業趨勢與策略舉措

企業合併（M&A）
夥伴關係、聯盟和合資企業
新產品發布和認證
擴大生產能力和投資
其他策略舉措

第13章：公司簡介

Pear Therapeutics
Click Therapeutics
Akili, Inc.
Onduo LLC
Livongo Health
Omada Health
Hinge Health
Better Therapeutics
DarioHealth Corp.
Kaia Health
Propeller Health
Roche Holding AG
Medtronic plc
ResMed Inc.
Philips Healthcare
Oracle Health

簡介目錄圖表

Product Code: SMRC39015

According to Stratistics MRC, the Global Digital Therapeutics Personalization Platforms Market is accounted for $2.5 billion in 2026 and is expected to reach $8.9 billion by 2034 growing at a CAGR of 17.2% during the forecast period. Digital therapeutics personalization platforms are software-based solutions that deliver evidence-based therapeutic interventions to patients, customized to their individual health profiles, behaviors, and preferences. These platforms use AI, machine learning, and real-time data from wearables and sensors to adapt treatment plans dynamically, ensuring optimal efficacy and patient engagement. They are designed to treat, manage, or prevent a broad spectrum of medical conditions, from mental health to chronic diseases.

Market Dynamics:

Driver:

Shift Towards Patient-Centric Precision Medicine

The growing shift from a one-size-fits-all approach to patient-centric, precision medicine is a key driver for platforms that can personalize treatment based on an individual's unique genetic, behavioral, and environmental data. Digital therapeutics platforms enable healthcare providers to deliver tailored interventions that are more effective and have better adherence. The increasing focus on outcomes-based care and the proven clinical efficacy of personalized therapies are accelerating the adoption of these platforms.

Restraint:

Clinical Evidence and Regulatory Standardization

The need for robust clinical evidence to demonstrate the efficacy and safety of personalized digital therapeutics remains a major challenge, requiring expensive and lengthy randomized controlled trials. The lack of standardized regulatory pathways for AI-driven adaptive therapies creates uncertainty for developers and can delay market entry. This need for rigorous clinical validation can be a significant barrier, especially for smaller companies, limiting the pace of innovation.

Opportunity:

Integration with Wearable Devices

The integration of personalization platforms with wearable devices and remote monitoring technologies offers a significant opportunity to continuously collect patient data and adapt therapy in real-time. This allows for dynamic, responsive interventions that can be adjusted based on immediate changes in the patient's condition. The growing consumer adoption of wearables and the development of advanced sensors are creating new avenues for data-driven personalization and market growth.

Threat:

Data Privacy and Security Concerns

The reliance on large amounts of sensitive patient health data makes digital therapeutics platforms a prime target for cyberattacks and data breaches, which could lead to significant financial losses and erosion of patient trust. The complexity of complying with diverse global data privacy regulations like HIPAA and GDPR adds to the compliance burden. Any major privacy scandal could severely undermine the credibility of the entire industry and limit adoption.

Covid-19 Impact:

The pandemic significantly accelerated the adoption of digital health and remote care, boosting interest in digital therapeutics. During the mid-pandemic period, the need for accessible and contactless mental health support drove the adoption of these platforms. Post-pandemic, the market is characterized by sustained growth, with a focus on integrating these solutions into mainstream healthcare delivery.

The chronic disease platforms segment is expected to be the largest during the forecast period

The chronic disease platforms segment is expected to account for the largest market share during the forecast period, due to the high prevalence of chronic conditions like diabetes and cardiovascular disease and the need for long-term, personalized management strategies. This segment benefits from the ability to integrate with various monitoring devices and provide continuous, data-driven support, which improves patient outcomes and reduces healthcare costs. The proven ROI of chronic disease management and the increasing focus on value-based care further secure its leading position.

The software segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the software segment is predicted to witness the highest growth rate, driven by the continuous innovation in AI algorithms and the development of sophisticated, user-friendly applications for both patients and clinicians. The growing adoption of cloud-based and AI-powered personalization engines is making these platforms more scalable and accessible. The rapid expansion of telehealth and remote monitoring is fueling demand for integrated software solutions, which in turn accelerates the growth of this key segment.

Region with largest share:

During the forecast period, North America is expected to hold the largest share of the Digital Therapeutics Personalization Platforms Market, driven by advanced healthcare infrastructure, high healthcare expenditure, and widespread adoption of digital health technologies. The United States leads the regional market with favorable reimbursement policies, strong regulatory support for digital therapeutics, and increasing integration of AI-powered personalized treatment platforms. The presence of major technology providers, growing consumer awareness, and rising demand for remote patient management further reinforce the region's market leadership.

Region with highest CAGR:

Over the forecast period, Asia Pacific is anticipated to register the highest CAGR in the Digital Therapeutics Personalization Platforms Market, supported by rapid healthcare digitalization, expanding smartphone and internet penetration, and increasing prevalence of chronic diseases. Countries including China, India, Japan, and South Korea are investing heavily in digital health initiatives and telemedicine infrastructure. Rising healthcare accessibility, supportive government policies, growing adoption of personalized care solutions, and increasing awareness of digital therapeutics are expected to accelerate market growth across the region.

Key players in the market

Some of the key players in Digital Therapeutics Personalization Platforms Market include Pear Therapeutics, Click Therapeutics, Akili, Inc., Onduo LLC, Livongo Health, Omada Health, Hinge Health, Better Therapeutics, DarioHealth Corp., Kaia Health, Propeller Health, Roche Holding AG, Medtronic plc, ResMed Inc., Philips Healthcare and Oracle Health.

Key Developments:

In July 2026, Omada Health launched a new digital therapeutics platform for chronic disease management, integrating real-time wearable data with AI-powered personalization to deliver adaptive treatment recommendations, improve patient engagement, and support long-term health outcomes.

In June 2026, Pear Therapeutics announced a partnership with a health insurance provider to expand access to its personalized digital therapeutics for mental health, improving reimbursement coverage, patient accessibility, treatment adherence, and clinical outcomes across broader populations.

In May 2026, Click Therapeutics introduced a new platform for personalized behavioral therapy, utilizing machine learning to continuously adapt interventions based on patient progress, enhancing treatment effectiveness, engagement, personalized care delivery, and long-term therapeutic outcomes.

Products Covered:

AI Personalization Platforms
Behavioral Therapy Platforms
Chronic Disease Platforms
Mental Health Platforms
Remote Monitoring Platforms
Adaptive Therapy Platforms
Digital Coaching Platforms

Components Covered:

Software
Services
Analytics Engines
Patient Applications
Clinical Dashboards
Integration Platforms
Cloud Infrastructure

Technologies Covered:

Artificial Intelligence
Machine Learning
Predictive Analytics
Natural Language Processing
Behavioral Analytics
Wearable Integration
Cloud Computing

Applications Covered:

Diabetes Management
Mental Health
Cardiovascular Care
Respiratory Care
Neurological Disorders
Obesity Management
Sleep Disorders

End Users Covered:

Hospitals
Clinics
Patients
Health Insurance Providers
Pharmaceutical Companies
Employers
Research Organizations

Regions Covered:

North America
- United States
- Canada
- Mexico
Europe
- United Kingdom
- Germany
- France
- Italy
- Spain
- Netherlands
- Belgium
- Sweden
- Switzerland
- Poland
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Vietnam
- Rest of Asia Pacific
South America
- Brazil
- Argentina
- Colombia
- Chile
- Peru
- Rest of South America
Rest of the World (RoW)
- Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
- Africa
South Africa
Egypt
Morocco
Rest of Africa

What our report offers:

Market share assessments for the regional and country-level segments
Strategic recommendations for the new entrants
Covers Market data for the years 2023, 2024, 2025, 2026, 2027, 2028, 2030, 2032 and 2034
Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
Strategic recommendations in key business segments based on the market estimations
Competitive landscaping mapping the key common trends
Company profiling with detailed strategies, financials, and recent developments
Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

Company Profiling
- Comprehensive profiling of additional market players (up to 3)
- SWOT Analysis of key players (up to 3)
Regional Segmentation
- Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
- Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

1 Executive Summary

1.1 Market Snapshot and Key Highlights
1.2 Growth Drivers, Challenges, and Opportunities
1.3 Competitive Landscape Overview
1.4 Strategic Insights and Recommendations

2 Research Framework

2.1 Study Objectives and Scope
2.2 Stakeholder Analysis
2.3 Research Assumptions and Limitations
2.4 Research Methodology
- 2.4.1 Data Collection (Primary and Secondary)
- 2.4.2 Data Modeling and Estimation Techniques
- 2.4.3 Data Validation and Triangulation
- 2.4.4 Analytical and Forecasting Approach

3 Market Dynamics and Trend Analysis

3.1 Market Definition and Structure
3.2 Key Market Drivers
3.3 Market Restraints and Challenges
3.4 Growth Opportunities and Investment Hotspots
3.5 Industry Threats and Risk Assessment
3.6 Technology and Innovation Landscape
3.7 Emerging and High-Growth Markets
3.8 Regulatory and Policy Environment
3.9 Impact of COVID-19 and Recovery Outlook

4 Competitive and Strategic Assessment

4.1 Porter's Five Forces Analysis
- 4.1.1 Supplier Bargaining Power
- 4.1.2 Buyer Bargaining Power
- 4.1.3 Threat of Substitutes
- 4.1.4 Threat of New Entrants
- 4.1.5 Competitive Rivalry
4.2 Market Share Analysis of Key Players
4.3 Product Benchmarking and Performance Comparison

5 Global Digital Therapeutics Personalization Platforms Market, By Product

5.1 AI Personalization Platforms
5.2 Behavioral Therapy Platforms
5.3 Chronic Disease Platforms
5.4 Mental Health Platforms
5.5 Remote Monitoring Platforms
5.6 Adaptive Therapy Platforms
5.7 Digital Coaching Platforms

6 Global Digital Therapeutics Personalization Platforms Market, By Component

6.1 Software
6.2 Services
6.3 Analytics Engines
6.4 Patient Applications
6.5 Clinical Dashboards
6.6 Integration Platforms
6.7 Cloud Infrastructure

7 Global Digital Therapeutics Personalization Platforms Market, By Technology

7.1 Artificial Intelligence
7.2 Machine Learning
7.3 Predictive Analytics
7.4 Natural Language Processing
7.5 Behavioral Analytics
7.6 Wearable Integration
7.7 Cloud Computing

8 Global Digital Therapeutics Personalization Platforms Market, By Application

8.1 Diabetes Management
8.2 Mental Health
8.3 Cardiovascular Care
8.4 Respiratory Care
8.5 Neurological Disorders
8.6 Obesity Management
8.7 Sleep Disorders

9 Global Digital Therapeutics Personalization Platforms Market, By End User

9.1 Hospitals
9.2 Clinics
9.3 Patients
9.4 Health Insurance Providers
9.5 Pharmaceutical Companies
9.6 Employers
9.7 Research Organizations

10 Global Digital Therapeutics Personalization Platforms Market, By Geography

10.1 North America
- 10.1.1 United States
- 10.1.2 Canada
- 10.1.3 Mexico
10.2 Europe
- 10.2.1 United Kingdom
- 10.2.2 Germany
- 10.2.3 France
- 10.2.4 Italy
- 10.2.5 Spain
- 10.2.6 Netherlands
- 10.2.7 Belgium
- 10.2.8 Sweden
- 10.2.9 Switzerland
- 10.2.10 Poland
- 10.2.11 Rest of Europe
10.3 Asia Pacific
- 10.3.1 China
- 10.3.2 Japan
- 10.3.3 India
- 10.3.4 South Korea
- 10.3.5 Australia
- 10.3.6 Indonesia
- 10.3.7 Thailand
- 10.3.8 Malaysia
- 10.3.9 Singapore
- 10.3.10 Vietnam
- 10.3.11 Rest of Asia Pacific
10.4 South America
- 10.4.1 Brazil
- 10.4.2 Argentina
- 10.4.3 Colombia
- 10.4.4 Chile
- 10.4.5 Peru
- 10.4.6 Rest of South America
10.5 Rest of the World (RoW)
- 10.5.1 Middle East
  - 10.5.1.1 Saudi Arabia
  - 10.5.1.2 United Arab Emirates
  - 10.5.1.3 Qatar
  - 10.5.1.4 Israel
  - 10.5.1.5 Rest of Middle East
- 10.5.2 Africa
  - 10.5.2.1 South Africa
  - 10.5.2.2 Egypt
  - 10.5.2.3 Morocco
  - 10.5.2.4 Rest of Africa

11 Strategic Market Intelligence

11.1 Industry Value Network and Supply Chain Assessment
11.2 White-Space and Opportunity Mapping
11.3 Product Evolution and Market Life Cycle Analysis
11.4 Channel, Distributor, and Go-to-Market Assessment

12 Industry Developments and Strategic Initiatives

12.1 Mergers and Acquisitions
12.2 Partnerships, Alliances, and Joint Ventures
12.3 New Product Launches and Certifications
12.4 Capacity Expansion and Investments
12.5 Other Strategic Initiatives

13 Company Profiles

13.1 Pear Therapeutics
13.2 Click Therapeutics
13.3 Akili, Inc.
13.4 Onduo LLC
13.5 Livongo Health
13.6 Omada Health
13.7 Hinge Health
13.8 Better Therapeutics
13.9 DarioHealth Corp.
13.10 Kaia Health
13.11 Propeller Health
13.12 Roche Holding AG
13.13 Medtronic plc
13.14 ResMed Inc.
13.15 Philips Healthcare
13.16 Oracle Health

簡介目錄圖表

List of Tables

Table 1 Global Digital Therapeutics Personalization Platforms Market Outlook, By Region (2023-2034) ($MN)
Table 2 Global Digital Therapeutics Personalization Platforms Market Outlook, By Product (2023-2034) ($MN)
Table 3 Global Digital Therapeutics Personalization Platforms Market Outlook, By AI Personalization Platforms (2023-2034) ($MN)
Table 4 Global Digital Therapeutics Personalization Platforms Market Outlook, By Behavioral Therapy Platforms (2023-2034) ($MN)
Table 5 Global Digital Therapeutics Personalization Platforms Market Outlook, By Chronic Disease Platforms (2023-2034) ($MN)
Table 6 Global Digital Therapeutics Personalization Platforms Market Outlook, By Mental Health Platforms (2023-2034) ($MN)
Table 7 Global Digital Therapeutics Personalization Platforms Market Outlook, By Remote Monitoring Platforms (2023-2034) ($MN)
Table 8 Global Digital Therapeutics Personalization Platforms Market Outlook, By Adaptive Therapy Platforms (2023-2034) ($MN)
Table 9 Global Digital Therapeutics Personalization Platforms Market Outlook, By Digital Coaching Platforms (2023-2034) ($MN)
Table 10 Global Digital Therapeutics Personalization Platforms Market Outlook, By Component (2023-2034) ($MN)
Table 11 Global Digital Therapeutics Personalization Platforms Market Outlook, By Software (2023-2034) ($MN)
Table 12 Global Digital Therapeutics Personalization Platforms Market Outlook, By Services (2023-2034) ($MN)
Table 13 Global Digital Therapeutics Personalization Platforms Market Outlook, By Analytics Engines (2023-2034) ($MN)
Table 14 Global Digital Therapeutics Personalization Platforms Market Outlook, By Patient Applications (2023-2034) ($MN)
Table 15 Global Digital Therapeutics Personalization Platforms Market Outlook, By Clinical Dashboards (2023-2034) ($MN)
Table 16 Global Digital Therapeutics Personalization Platforms Market Outlook, By Integration Platforms (2023-2034) ($MN)
Table 17 Global Digital Therapeutics Personalization Platforms Market Outlook, By Cloud Infrastructure (2023-2034) ($MN)
Table 18 Global Digital Therapeutics Personalization Platforms Market Outlook, By Technology (2023-2034) ($MN)
Table 19 Global Digital Therapeutics Personalization Platforms Market Outlook, By Artificial Intelligence (2023-2034) ($MN)
Table 20 Global Digital Therapeutics Personalization Platforms Market Outlook, By Machine Learning (2023-2034) ($MN)
Table 21 Global Digital Therapeutics Personalization Platforms Market Outlook, By Predictive Analytics (2023-2034) ($MN)
Table 22 Global Digital Therapeutics Personalization Platforms Market Outlook, By Natural Language Processing (2023-2034) ($MN)
Table 23 Global Digital Therapeutics Personalization Platforms Market Outlook, By Behavioral Analytics (2023-2034) ($MN)
Table 24 Global Digital Therapeutics Personalization Platforms Market Outlook, By Wearable Integration (2023-2034) ($MN)
Table 25 Global Digital Therapeutics Personalization Platforms Market Outlook, By Cloud Computing (2023-2034) ($MN)
Table 26 Global Digital Therapeutics Personalization Platforms Market Outlook, By Application (2023-2034) ($MN)
Table 27 Global Digital Therapeutics Personalization Platforms Market Outlook, By Diabetes Management (2023-2034) ($MN)
Table 28 Global Digital Therapeutics Personalization Platforms Market Outlook, By Mental Health (2023-2034) ($MN)
Table 29 Global Digital Therapeutics Personalization Platforms Market Outlook, By Cardiovascular Care (2023-2034) ($MN)
Table 30 Global Digital Therapeutics Personalization Platforms Market Outlook, By Respiratory Care (2023-2034) ($MN)
Table 31 Global Digital Therapeutics Personalization Platforms Market Outlook, By Neurological Disorders (2023-2034) ($MN)
Table 32 Global Digital Therapeutics Personalization Platforms Market Outlook, By Obesity Management (2023-2034) ($MN)
Table 33 Global Digital Therapeutics Personalization Platforms Market Outlook, By Sleep Disorders (2023-2034) ($MN)
Table 34 Global Digital Therapeutics Personalization Platforms Market Outlook, By End User (2023-2034) ($MN)
Table 35 Global Digital Therapeutics Personalization Platforms Market Outlook, By Hospitals (2023-2034) ($MN)
Table 36 Global Digital Therapeutics Personalization Platforms Market Outlook, By Clinics (2023-2034) ($MN)
Table 37 Global Digital Therapeutics Personalization Platforms Market Outlook, By Patients (2023-2034) ($MN)
Table 38 Global Digital Therapeutics Personalization Platforms Market Outlook, By Health Insurance Providers (2023-2034) ($MN)
Table 39 Global Digital Therapeutics Personalization Platforms Market Outlook, By Pharmaceutical Companies (2023-2034) ($MN)
Table 40 Global Digital Therapeutics Personalization Platforms Market Outlook, By Employers (2023-2034) ($MN)
Table 41 Global Digital Therapeutics Personalization Platforms Market Outlook, By Research Organizations (2023-2034) ($MN)